Dr Gus Konstantine George Varnavas, MD | |
401 W Pennsylvania Ave, Anaconda, MT 59711-1931 | |
(406) 563-8500 | |
Not Available |
Full Name | Dr Gus Konstantine George Varnavas |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 401 W Pennsylvania Ave, Anaconda, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053418582 | NPI | - | NPPES |
1053418582 | Medicaid | MT | |
1053418582 | Other | MT | NPI |
8341 | Other | MT | STATE LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 8341 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gus Konstantine George Varnavas, MD 401 W Pennsylvania Ave, Anaconda, MT 59711-1931 Ph: (406) 563-8500 | Dr Gus Konstantine George Varnavas, MD 401 W Pennsylvania Ave, Anaconda, MT 59711-1931 Ph: (406) 563-8500 |
News Archive
A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.
Researchers in the University of Georgia's Regenerative Bioscience Center are visually capturing the first process of chromosome alignment and separation at the beginning of mouse development. The findings could lead to answers to questions concerning the mechanisms leading to birth defects and chromosome instability in cancer cells.
It is expected that the clinical trial management systems (CTMS) market will achieve a value of $1.76 billion by 2017, according to a new report on companiesandmarkets.com.
After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center investigated why the complication occurred, performing a molecular analysis of the disease's pathology and mining data to determine the incidence of similar occurrences.
› Verified 3 days ago